Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCOVID convalescent plasma for severe COVID-19
NL-OMON50016Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Erasmus MC. Primary endpoint: Overall mortality. Started Apr 2020; status: active, not recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON50016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50016.